http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101243367-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
filingDate 2010-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2013-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101243367-B1
titleOfInvention Screening methods for substances that enhance the radiation sensitivity of radiation non-reactive cancer cells
abstract The present invention comprises the steps of (a) contacting a radioactive non-reactive cell line lacking the function of a gene encoding TERC and a constitutive protein of telomerase and a gene encoding a cancer suppressor, (b) irradiating with radiation (C) measuring the level of colony formation in the cell line, and (d) selecting candidates whose degree of colony formation in step (c) is reduced compared to the control group that did not process the candidates. The present invention relates to a method for screening a substance that enhances radiation sensitivity of radiation non-reactive cancer cells. In addition, the present invention (a) contacting a radioactive non-reactive cell line and a radiation-reactive cell line with a gene encoding TERC, a constitutive protein of telomerase, and a function of a gene encoding a cancer suppressor, with a candidate, ( b) irradiating with radiation, (c) measuring the level of colony formation in said cell line, and (d) selecting candidates for which the degree of colony formation in step (c) is similar to a radiation reactive cell line; The present invention relates to a method for screening a substance that enhances radiation sensitivity of radiation non-reactive cancer cells. The screening method of the present invention is to improve the radiation sensitivity of tumor cells to DNA damage factors such as anticancer agents or radiation to select a substance that maximizes the apoptosis effect of the tumor cells by using as a chemotherapy in combination with radiation therapy or chemotherapy Effective chemotherapy is possible.
priorityDate 2010-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397276
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID820408
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID616369
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23072
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21328
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO76332
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID465021
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID455214
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100271861
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DV86
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100379269
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO70372
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DV89
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO77448
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DV94
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9NBX4
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403869
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395076
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ4KTA7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24842
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08548
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12578
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ46666
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396200
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24708
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23070
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25163
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7157
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID22059
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494923
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395077
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID476915
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9SPU7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21329
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO14746
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID554242
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DV59
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ47526
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8LKW0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ673L6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6A548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23940
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281542
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397926
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO00939
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ95SX7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1029
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1PS67
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19593
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP71276
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27ID4
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID220401
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ94818
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30590
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO13339
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ94819
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06163

Total number of triples: 73.